Miami, FL, United States of America

Pamela L Hawkins


Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1984-1996

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations in Thromboplastin Reagents by Pamela L Hawkins

Introduction

Pamela L Hawkins is a notable inventor based in Miami, FL, who has made significant contributions to the field of medical diagnostics. With a total of four patents to her name, her work primarily focuses on improving the sensitivity and effectiveness of thromboplastin reagents used in blood coagulation tests.

Latest Patents

One of her latest patents involves extraction methods for preparing thromboplastin reagents. The Prothrombin Time (PT) test is essential for screening blood coagulation factor deficiencies and monitoring oral anti-coagulant therapy using coumadin. Hawkins' invention describes the innovative use of barium sulfate, chaotropic agents, and nonionic detergents for extracting sensitive thromboplastin reagents from tissue. Additionally, extraction with sodium thiocyanate alone significantly enhances thromboplastin sensitivity. This invention is expected to be beneficial for all thromboplastins, improving their sensitivity for PT-based tests and specific assays.

Career Highlights

Throughout her career, Pamela has worked with prominent companies such as Baxter Diagnostics Inc. and American Hospital Supply Corporation. Her experience in these organizations has contributed to her expertise in the field of medical diagnostics and reagent development.

Collaborations

Pamela has collaborated with notable individuals in her field, including James R Maynard and Carole J Young. These collaborations have likely enriched her work and contributed to her innovative approaches in thromboplastin reagent extraction.

Conclusion

Pamela L Hawkins is a distinguished inventor whose work in thromboplastin reagents has the potential to enhance blood coagulation testing significantly. Her innovative methods and collaborations reflect her commitment to advancing medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…